Chakera Annette H, Hesse Birger, Burak Zeynep, Ballinger James R, Britten Allan, Caracò Corrado, Cochran Alistair J, Cook Martin G, Drzewiecki Krzysztof T, Essner Richard, Even-Sapir Einat, Eggermont Alexander M M, Stopar Tanja Gmeiner, Ingvar Christian, Mihm Martin C, McCarthy Stanley W, Mozzillo Nicola, Nieweg Omgo E, Scolyer Richard A, Starz Hans, Thompson John F, Trifirò Giuseppe, Viale Giuseppe, Vidal-Sicart Sergi, Uren Roger, Waddington Wendy, Chiti Arturo, Spatz Alain, Testori Alessandro
Department of Plastic Surgery and Burns Unit, Rigshospitalet, Copenhagen, Denmark.
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1713-42. doi: 10.1007/s00259-009-1228-4.
The accurate diagnosis of a sentinel node in melanoma includes a sequence of procedures from different medical specialities (nuclear medicine, surgery, oncology, and pathology). The items covered are presented in 11 sections and a reference list: (1) definition of a sentinel node, (2) clinical indications, (3) radiopharmaceuticals and activity injected, (4) dosimetry, (5) injection technique, (6) image acquisition and interpretation, (7) report and display, (8) use of dye, (9) gamma probe detection, (10) surgical techniques in sentinel node biopsy, and (11) pathological evaluation of melanoma-draining sentinel lymph nodes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "general consensus" and similar expressions. The recommendations are designed to assist in the practice of referral to, performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for good-quality evaluation of possible spread to the lymphatic system in intermediate-to-high risk melanoma without clinical signs of dissemination.
黑色素瘤前哨淋巴结的准确诊断包括一系列来自不同医学专业(核医学、外科、肿瘤学和病理学)的程序。涵盖的内容分为11个部分和一个参考文献列表:(1)前哨淋巴结的定义,(2)临床适应症,(3)放射性药物及注射剂量,(4)剂量测定,(5)注射技术,(6)图像采集与解读,(7)报告与展示,(8)染料的使用,(9)γ探针检测,(10)前哨淋巴结活检的手术技术,以及(11)黑色素瘤引流前哨淋巴结的病理评估。如果给出的具体建议无法基于原始科学研究的证据,则参考“普遍共识”及类似表述。这些建议旨在协助前哨淋巴结程序所有步骤的转诊、操作、解读和报告,以期为评估中高危黑色素瘤在无临床播散迹象时可能向淋巴系统扩散的高质量评估设定最新标准。